Compare DLPN & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLPN | BNGO |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 11.6M |
| IPO Year | 2008 | 2018 |
| Metric | DLPN | BNGO |
|---|---|---|
| Price | $1.60 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 33.2K | ★ 98.5K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.81 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $51,684,984.00 | $12,000,735.00 |
| Revenue This Year | $10.62 | N/A |
| Revenue Next Year | $13.78 | $24.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 19.85 | ★ 26.26 |
| 52 Week Low | $0.75 | $1.06 |
| 52 Week High | $1.88 | $5.50 |
| Indicator | DLPN | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 38.12 |
| Support Level | $1.51 | $1.06 |
| Resistance Level | $1.71 | $1.18 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 8.07 | 29.70 |
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.